KraneShares MSCI All China Health Care Index ETF
Health/Biotechnology
KURE
280 Park Ave,32nd Floor
NEW YORK , NY, 10017
NEW YORK , NY, 10017
Price
-
$ 14.37
0 %
+0.06
Dec 19, 2024
- Last Close
- Net Assets
-
$60.6M
Feb 28, 2024
- 52-Week High/Low
- $20.27 - $12.97
- Expense Ratio
- -
Link
Directors
Jun 14, 2023- Matthew Stroyman
- Patrick P. Campo
- Jonathan Krane
- John Ferguson
Chief Compliance Officer
- Michael Quain
Company Name |
Holding |
| More | 1.37 % |
Returns +
Q
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Q1 | -16.9% | -4.1% | -18.9% | 282% | 2.8% | 28.4% |
| Q2 | -5.9% | -12.2% | 0.4% | -6% | 34% | -9.6% |
| Q3 | - | -1.5% | -24.2% | -11.2% | 5.1% | 1.7% |
| Q4 | - | -0.6% | 20.7% | -4% | -12% | 10% |
Returns +
M
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -19% | 10% | -6.7% | 1.1% | -3.4% | - | - | - | - | - | - | - |
| 2023 | 8.6% | -7.2% | -4.8% | 2.2% | -9.4% | -5.1% | 6.1% | -8.3% | 1.2% | 3.2% | 1.6% | -6% |
Returns +
A
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.9% | -18.2% | -25.5% | -2.6% | 27.3% | 34.1% | 0% | 11.8% | 6.8% | -11.4% | -3% |